|
EIF5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.292100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.640100E-02 |
| Normal-vs-Stage2 |
5.103800E-01 |
| Normal-vs-Stage3 |
4.815600E-02 |
| Normal-vs-Stage4 |
7.425500E-02 |
| Stage1-vs-Stage2 |
8.855600E-01 |
| Stage1-vs-Stage3 |
3.332800E-01 |
| Stage1-vs-Stage4 |
1.278640E-01 |
| Stage2-vs-Stage3 |
4.354600E-01 |
| Stage2-vs-Stage4 |
1.315230E-01 |
| Stage3-vs-Stage4 |
2.192400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.860600E-01 |
| Normal-vs-AfricanAmerican |
1.335900E-02 |
| Normal-vs-Asian |
6.563600E-01 |
| Caucasian-vs-AfricanAmerican |
6.534400E-02 |
| Caucasian-vs-Asian |
7.916800E-01 |
| AfricanAmerican-vs-Asian |
7.139400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.925800E-01 |
| Normal-vs-Female |
5.557200E-04 |
| Male-vs-Female |
4.790800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.791200E-01 |
| Normal-vs-Extreme_Weight |
7.414600E-01 |
| Normal-vs-Obese |
2.505600E-02 |
| Normal-vs-Extreme_Obese |
9.734600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.009600E-01 |
| Normal_Weight-vs-Obese |
4.879800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.924600E-01 |
| Extreme_Weight-vs-Obese |
1.338480E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.495800E-01 |
| Obese-vs-Extreme_Obese |
3.072000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.528000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.144400E-03 |
| Normal-vs-Age(61-80Yrs) |
9.438800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.943600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.772800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.282200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.360500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.261700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.828200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.482000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.405800E-02 |
| Normal-VS-Type2 PRCC |
7.864600E-01 |
| Normal-VS-KIRP CIMP |
7.503800E-03 |
| Normal-VS-Unclassified PRCC |
1.089560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.940000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.980500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.524200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.579250E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.151800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.574100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.997400E-01 |
| Normal-vs-N1 |
8.022400E-04 |
| Normal-vs-N2 |
3.006400E-01 |
| N0-vs-N1 |
9.85749999999896E-05 |
| N0-vs-N2 |
2.883600E-01 |
| N1-vs-N2 |
6.133600E-01 |
|
|
